Collaborative Fund Advisors LLC Purchases 21,838 Shares of Koninklijke Philips N.V. $PHG

Collaborative Fund Advisors LLC bought a new position in Koninklijke Philips N.V. (NYSE:PHG) in the 3rd quarter, HoldingsChannel.com reports. The firm bought 21,838 shares of the technology company’s stock, valued at approximately $534,000.

Several other institutional investors and hedge funds also recently made changes to their positions in PHG. Bank of America Corp DE grew its position in Koninklijke Philips by 7.7% in the 1st quarter. Bank of America Corp DE now owns 700,141 shares of the technology company’s stock worth $19,184,000 after purchasing an additional 50,124 shares in the last quarter. Investment Management Associates Inc. ADV lifted its position in shares of Koninklijke Philips by 1.5% during the 1st quarter. Investment Management Associates Inc. ADV now owns 515,007 shares of the technology company’s stock worth $14,111,000 after buying an additional 7,743 shares in the last quarter. Royal Bank of Canada lifted its position in shares of Koninklijke Philips by 13.1% during the 1st quarter. Royal Bank of Canada now owns 495,310 shares of the technology company’s stock worth $13,572,000 after buying an additional 57,514 shares in the last quarter. Sei Investments Co. lifted its holdings in Koninklijke Philips by 4.7% during the first quarter. Sei Investments Co. now owns 486,941 shares of the technology company’s stock worth $13,343,000 after acquiring an additional 22,039 shares during the period. Finally, Tidal Investments LLC boosted its position in Koninklijke Philips by 18.9% in the second quarter. Tidal Investments LLC now owns 401,637 shares of the technology company’s stock worth $10,921,000 after purchasing an additional 63,868 shares during the last quarter. Hedge funds and other institutional investors own 13.67% of the company’s stock.

More Koninklijke Philips News

Here are the key news stories impacting Koninklijke Philips this week:

• Positive Sentiment: Philips reported third-quarter adjusted earnings of $0.45 per share, above the $0.37 analyst consensus. Comparable order intake rose 8%, sales grew 3%, and the adjusted EBITA margin expanded 70 basis points to 13.0%. The company generated €544 million in operating cash flow and reaffirmed its full-year 2026 outlook. Philips Q3 2026 results
• Positive Sentiment: Philips reached an agreement in principle with the U.S. Department of Justice related to investigations stemming from Respironics product recalls. Resolving these matters could reduce a source of legal uncertainty, though the agreement is not described as finalized. Philips sales rise amid product recall agreement
• Positive Sentiment: The company launched HyperVue Integrated in the U.S., combining coronary imaging and AI-supported physiology assessment to streamline workflows for heart procedures. The launch adds to Philips’ product innovation, although its near-term financial contribution is unclear. Philips launches HyperVue Integrated system
• Negative Sentiment: Quarterly revenue of $4.98 billion came in slightly below the $5.01 billion consensus, despite year-over-year growth. A Seeking Alpha contributor also downgraded the stock, saying they had been too optimistic about the recovery; this may temper enthusiasm about the results. Philips quarterly earnings results Philips rating downgrade

Koninklijke Philips Trading Up 9.0%

NYSE:PHG opened at $31.01 on Thursday. Koninklijke Philips N.V. has a 1 year low of $23.62 and a 1 year high of $33.44. The stock’s fifty day moving average price is $25.62 and its two-hundred day moving average price is $27.23. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.26 and a quick ratio of 0.82. The company has a market cap of $30.48 billion, a P/E ratio of 14.23, a P/E/G ratio of 11.88 and a beta of 0.74.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on PHG shares. Zacks Research upgraded shares of Koninklijke Philips from a “strong sell” rating to a “hold” rating in a report on Thursday, August 13th. UBS Group cut shares of Koninklijke Philips from a “buy” rating to a “neutral” rating in a research note on Monday, August 3rd. Finally, Weiss Ratings upgraded shares of Koninklijke Philips from a “hold (c)” rating to a “hold (c+)” rating in a research note on Wednesday, October 21st. Five equities research analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, the company presently has an average rating of “Hold”.

Koninklijke Philips Profile

Koninklijke Philips N.V. is a Netherlands-based health technology company that develops products, services and software for healthcare providers, patients and consumers. Its portfolio includes diagnostic imaging systems, such as magnetic resonance imaging, computed tomography and X-ray equipment; ultrasound systems; image-guided therapy technologies; patient monitoring and hospital informatics solutions; and connected care products.

Philips also serves consumers through personal health products, including electric toothbrushes, oral healthcare systems, mother and child care products, and sleep and respiratory care devices.